Research Article
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
Table 1
Basic characteristics of HCC patients from the TCGA, GSE14520, and ICGC HCC cohorts.
| | Variables | TCGA cohort () | GSE14520 cohort () | ICGC cohort () |
| | Gender (male/female) | 255/122 | 190/30 | 171/61 | | Age (years, median) | 60 (16-90) | 50 (21-77) | 69 (31-89) | | Cirrhosis (yes/no/NA) | 81/137/159 | 202/18 | NA | | Histologic grade (G1/G2/G3/G4/NA) | 55/180/124/13/5 | NA | NA | | TNM stage (I/II/III/IV/NA) | 175/87/86/5/24 | 93/77/48/-/2 | 36/106/71/76 | | Main tumor size (>/≤5 cm) | NA | 80/140 | NA | | Overall survival status (alive/dead) | 245/132 | 136/84 | 189/43 | | Overall survival time (months, median) | 19.67 (0-120.73) | 51.65 (1.8-67.4) | 26.0 (0.3-72) |
|
|
